CM
HZNP

Capula Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Capula Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-225,000
Closed -$26M – 636
2023
Q3 		$26M Sell
225,000
-75,000
-25% -$8.06M 0.55% 29
2023
Q2 		$30.9M Buy
+300,000
New +$31.7M 0.75% 24

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Capula Management's HZNP Position: Q4 2023 in Review

Capula Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 242,048 shares — an estimated $28M sold.

Capula Management first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $28M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Capula Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Capula Management sold 242,048 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $28M.
  • Capula Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
  • Capula Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $28M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Capula Management's 13F filing for Q4 2023, filed 12 Feb 2024.